Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$26.13 - $33.94 $116,409 - $151,202
4,455 Added 4.43%
105,067 $3.02 Million
Q3 2023

Oct 20, 2023

BUY
$32.09 - $37.51 $63,570 - $74,307
1,981 Added 2.01%
100,612 $3.34 Million
Q2 2023

Jul 24, 2023

BUY
$36.12 - $41.79 $169,655 - $196,287
4,697 Added 5.0%
98,631 $3.62 Million
Q1 2023

Apr 12, 2023

SELL
$39.39 - $51.28 $55,815 - $72,663
-1,417 Reduced 1.49%
93,934 $3.83 Million
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $333,373 - $435,182
7,985 Added 9.14%
95,351 $0
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $139,813 - $170,676
3,195 Added 3.8%
87,366 $3.82 Million
Q2 2022

Jul 25, 2022

BUY
$46.53 - $55.17 $110,694 - $131,249
2,379 Added 2.91%
84,171 $4.41 Million
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $567,300 - $702,956
12,400 Added 17.87%
81,792 $4.07 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $449,065 - $665,665
10,868 Added 18.57%
69,392 $4.1 Million
Q3 2021

Oct 18, 2021

BUY
$39.25 - $50.42 $578,545 - $743,190
14,740 Added 33.67%
58,524 $2.52 Million
Q2 2021

Jul 19, 2021

BUY
$35.91 - $40.68 $262,071 - $296,882
7,298 Added 20.0%
43,784 $1.72 Million
Q1 2021

Apr 21, 2021

BUY
$33.49 - $37.77 $274,450 - $309,525
8,195 Added 28.97%
36,486 $1.32 Million
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $164,371 - $209,012
4,911 Added 21.01%
28,291 $1.04 Million
Q3 2020

Feb 03, 2021

SELL
$31.75 - $37.25 $5,238 - $6,146
-165 Reduced 0.7%
23,380 $858,000
Q2 2020

Feb 03, 2021

BUY
$30.12 - $36.54 $709,175 - $860,334
23,545 New
23,545 $770,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ellsworth Advisors, LLC Portfolio

Follow Ellsworth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellsworth Advisors, LLC with notifications on news.